TENDER AGREEMENT Dated as of December 15, 2013 among VALEANT PHARMACEUTICALS INTERNATIONAL, SAPPHIRE SUBSIDIARY CORP. and JOHN GLENNTender Agreement • December 23rd, 2013 • Valeant Pharmaceuticals International, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledDecember 23rd, 2013 Company Industry JurisdictionThis TENDER AGREEMENT, dated as of December 15, 2013 (this “Agreement”), is among Valeant Pharmaceuticals International, a Delaware corporation (“Parent”), Sapphire Subsidiary Corp., a Delaware corporation and a wholly owned Subsidiary of Parent (“Merger Sub”), and John Glenn (“Company Stockholder”).
CONFIDENTIALITY AGREEMENTConfidentiality Agreement • December 23rd, 2013 • Valeant Pharmaceuticals International, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledDecember 23rd, 2013 Company Industry JurisdictionThis CONFIDENTIALITY AGREEMENT (“Agreement”) is being entered into as of July 7, 2012 between Solta Medical, Inc., a Delaware corporation (“SMI”) and Valeant Pharmaceuticals International, Inc., a Canadian corporation (“VPII” and with SMI referred to collectively as the “Parties” and individually as a “Party”).
October 31, 2013Confidentiality Agreement • December 23rd, 2013 • Valeant Pharmaceuticals International, Inc. • Pharmaceutical preparations
Contract Type FiledDecember 23rd, 2013 Company Industry